Obeticholic acid, a synthetic FXR agonist, prevents hepatic inflammation and fibrosis in a novel mouse model of non-alcoholic steatohepatitis

被引：0
|
作者：
Goto, Toshihiro [1 ,2 ]
Itoh, Michiko [2 ]
Kanai, Sayaka [2 ]
Suganami, Takayoshi [3 ,4 ]
Ogawa, Yoshihiro [2 ,5 ]
机构：
[1] Sumitomo Dainippon Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
[3] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[4] JST PRESTO, Tokyo, Japan
[5] AMED CREST, Tokyo, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1609
引用
收藏
页码：797A / 798A
页数：2
相关论文
共 50 条
  • [21] Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis
    Sugino, Haruko
    Kumagai, Naoki
    Watanabe, Sakiko
    Toda, Kyoko
    Takeuchi, Osamu
    Tsunematsu, Satoshi
    Morinaga, Shojiroh
    Tsuchimoto, Kanji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (12) : 1909 - 1916
  • [22] An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
    Matsumoto, Masahiko
    Hada, Natsuko
    Sakamaki, Yoshiyuki
    Uno, Akiko
    Shiga, Toshihiko
    Tanaka, Chiaki
    Ito, Tsuneo
    Katsume, Asao
    Sudoh, Masayuki
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2013, 94 (02) : 93 - 103
  • [23] Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats
    Nishi, Toshio
    Yamamoto, Yuta
    Yamagishi, Naoko
    Iguchi, Mikitaka
    Tamai, Hideyuki
    Ito, Takao
    Tsuruo, Yoshihiro
    Ichinose, Masao
    Kitano, Masayuki
    Ueyama, Takashi
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (03) : 383 - 392
  • [24] Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
    Stefano, J. T.
    Pereira, I. V. A.
    Torres, M. M.
    Bida, P. M.
    Coelho, A. M. M.
    Xerfan, M. P.
    Cogliati, B.
    Barbeiro, D. F.
    Mazo, D. F. C.
    Kubrusly, M. S.
    D'Albuquerque, L. A. C.
    Souza, H. P.
    Carrilho, F. J.
    Oliveira, C. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (05) : 408 - 414
  • [25] Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non-alcoholic steatohepatitis mouse model
    Ishii, Yui
    Tsuchiya, Atsunori
    Natsui, Kazuki
    Koseki, Youhei
    Takeda, Nobutaka
    Tomiyoshi, Kei
    Yamazaki, Fusako
    Yoshida, Yuki
    Shimbo, Takashi
    Tamai, Katsuto
    Terai, Shuji
    HEPATOLOGY RESEARCH, 2022, 52 (12) : 985 - 997
  • [26] OBETICHOLIC ACID FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS:AN EARLY ECONOMIC EVALUATION
    Tran, Phong
    Wong, William W. L.
    MEDICAL DECISION MAKING, 2021, 41 (04) : E28 - E28
  • [27] Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
    Siddiqui, Mohammad Shadab
    Van Natta, Mark L.
    Connelly, Margery A.
    Vuppalanchi, Raj
    Neuschwander-Tetri, Brent A.
    Tonascia, James
    Guy, Cynthia
    Loomba, Rohit
    Dasarathy, Srinivasan
    Wattacheril, Julia
    Chalasani, Naga
    Sanyal, Arun J.
    Allende, Daniela
    Bellar, Annette
    Dasarathy, Jaividhya
    McCullough, Arthur J.
    Penumatsa, Revathi
    Reen, Jaspreet S.
    Lavine, Joel E.
    Abdelmalek, Manal F.
    Bashir, Mustafa
    Buie, Stephanie
    Diehl, Anna Mae
    Kigongo, Christopher
    Kopping, Mariko
    Piercy, Dawn
    Tawadrous, Naglaa
    Cummings, Oscar W.
    Gawrieh, Samer
    Ragozzino, Linda
    Rank, Dawn
    Samala, Niharika
    Brunt, Elizabeth M.
    Cattoor, Theresa
    Carpenter, Danielle
    Freebersyser, Janet
    King, Debra
    Lai, Jinping
    Siegner, Joan
    Stewart, Susan
    Torretta, Susan
    Wriston, Kristina
    Gonzalez, Maria Cardona
    Davila, Jodie
    Kowdley, Kris, V
    Mukhtar, Nizar
    Poitevin, Michelle
    Quist, Brook
    Soo, Sherilynn
    Behling, Cynthia
    JOURNAL OF HEPATOLOGY, 2020, 72 (01) : 25 - 33
  • [28] CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis
    Song, Yiran
    Li, Chenyang
    Luo, Yuxin
    Guo, Jinbo
    Kang, Yaxing
    Yin, Fengrong
    Ye, Lihong
    Sun, Donglei
    Yu, Jun
    Zhang, Xiaolan
    LIVER INTERNATIONAL, 2023, 43 (02) : 357 - 369
  • [29] Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis
    Amano, Yuichiro
    Tsuchiya, Shuntarou
    Imai, Mayumi
    Tohyama, Kimio
    Matsukawa, Jun
    Isono, Osamu
    Yasuno, Hironobu
    Enya, Kazuaki
    Koumura, Emiko
    Nagabukuro, Hiroshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 207 - 213
  • [30] Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida, M.
    Hashimoto, K.
    Ishikawa, T.
    Miyamoto, Y.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
12345